Medical device company Masimo unveils the iSpO2, the 1st Apple-approved pulse oximetry system compatible with iPods, iPhones and iPads.

Medical device maker Masimo (NSDQ:MASI) today unveiled its iSpO2, a novel pulse oximetry system for use with iPods, iPhones and iPads, the company's 1st consumer-marketed product.
Patients can use the iSpO2 device to measure blood oxygenation, pulse rate and a perfusion index using a finger sensor and a cable that connects to their mobile devices.
Concerns that the medical device tax will push companies to lay off workers and move operations...
The FDA clears OrthoSensor's Verasense device, designed to help surgeons fit knee replacement...
ArtVentive Medical Group wins CE Mark approval in the European Union for its EOS peripheral vascular...
The FDA hits Endologix's catheter introducer device recall with Class I status, its most serious...
A blogger's speculation that pSivida might be in line for a buyout bid sends the ophthalmology...